Wednesday, June 10, 2026
🇺🇸 FDA

pharma · Breast Cancer · Prostate Cancer · UTHR

United Therapeutics Europe

United Therapeutics Europe Ltd

United Therapeutics Europe clinical programs — 121 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
1000 Spring Street, Silver Spring, Maryland 20910, US HQ
1996 Founded
1,443 Employees
Public company Type
UTHR · NYSE Ticker
Company details
Status
Public
HQ
1000 Spring Street, Silver Spring, Maryland 20910, US
Founded
1996
Employees
1,443
Programs
1032
Drugs
612
Patents
3720
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

United Therapeutics Europe projects

121 ClinicalTrials.gov programs sponsored by United Therapeutics Europe.

United Therapeutics Europe has 121 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

121 programs

Clinical programs

Page 1 of 3

  1. 0.1% bupivacaine

    United Therapeutics Europe Ltd

    Pregnancy

    approved small molecule active

    1 trial

  2. 25-0256

    United Therapeutics Europe Ltd

    Frostbite

    approved small molecule active

    1 trial

  3. 50,000 Units Ergocalciferol

    United Therapeutics Europe Ltd

    Pruritis

    approved small molecule completed

    1 trial

  4. AL (Coartem)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  5. Academic Detailing

    United Therapeutics Europe Ltd

    Prostate Cancer

    approved other terminated

    1 trial

  6. Acetazolamide

    United Therapeutics Europe Ltd

    Hypobaric Hypoxia

    approved small molecule active

    1 trial

  7. Active Procedure

    United Therapeutics Europe Ltd

    Low Back Pain

    approved other completed

    1 trial

  8. Albendazole

    United Therapeutics Europe Ltd

    Ascariasis

    approved small molecule completed

    1 trial

  9. Aliskiren

    United Therapeutics Europe Ltd

    IgA Nephropathy

    approved small molecule completed

    1 trial

  10. Ambulatory Oxygen

    United Therapeutics Europe Ltd

    Lung; Disease, Fibroid (Chronic)

    approved small molecule completed

    1 trial

  11. Amodiaquine plus Artesunate co-administration

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  12. Antiepileptic drug therapy

    United Therapeutics Europe Ltd

    Epilepsy

    approved small molecule active

    1 trial

  13. Aripiprazole

    United Therapeutics Europe Ltd

    Hyperprolactinemia

    approved small molecule completed

    1 trial

  14. Arm A: ABC+3TC+NNRTI

    United Therapeutics Europe Ltd

    Human Immunodeficiency Virus

    approved small molecule completed

    1 trial

  15. Artemether-lumefantrine combination

    United Therapeutics Europe Ltd

    Plasmodium Vivax Infection

    approved small molecule completed

    1 trial

  16. Artesunate-amodiaquine combination

    United Therapeutics Europe Ltd

    Malaria,Falciparum

    approved small molecule completed

    1 trial

  17. Atorvastatin

    United Therapeutics Europe Ltd

    Major Coronary Event

    approved small molecule completed

    1 trial

  18. Atorvastatin 20mg

    United Therapeutics Europe Ltd

    Cardiovascular Disease

    approved small molecule completed

    1 trial

  19. Azithromycin

    United Therapeutics Europe Ltd

    Typhoid Fever

    approved small molecule completed

    1 trial

  20. Azithromycin Pill

    United Therapeutics Europe Ltd

    Chronic Obstructive Pulmonary Disease

    approved small molecule active

    1 trial

  21. Biomarker

    United Therapeutics Europe Ltd

    Transplantation, Liver

    approved gene therapy terminated

    1 trial

  22. Botulinum Toxin A

    United Therapeutics Europe Ltd

    Low Back Pain

    approved small molecule terminated

    1 trial

  23. Bubble-Enhanced FAST (BEFAST)

    United Therapeutics Europe Ltd

    Abdominal Trauma

    approved small molecule completed

    1 trial

  24. Bupivacaine

    United Therapeutics Europe Ltd

    Amputation Stumps

    approved small molecule completed

    1 trial

  25. CRoC

    United Therapeutics Europe Ltd

    Hemorrhage

    approved other completed

    1 trial

  26. Carbetocin Short-infusion

    United Therapeutics Europe Ltd

    Complications; Cesarean Section

    approved small molecule completed

    1 trial

  27. Cefecin Tab.

    United Therapeutics Europe Ltd

    Acute Sinusitis

    approved small molecule terminated

    1 trial

  28. Cetrorelix Acetate

    United Therapeutics Europe Ltd

    Infertility

    approved small molecule active

    1 trial

  29. Chlorhexidine

    United Therapeutics Europe Ltd

    Pneumonia

    approved other completed

    1 trial

  30. Chloroquine

    United Therapeutics Europe Ltd

    Malaria, Falciparum

    approved small molecule completed

    1 trial

  31. Cholecalciferol

    United Therapeutics Europe Ltd

    Crohn Disease

    approved other active

    1 trial

  32. Coartem™ (Artemether-lumefantrine combination)

    United Therapeutics Europe Ltd

    Malaria

    approved small molecule completed

    1 trial

  33. Copper IUD

    United Therapeutics Europe Ltd

    Mucosal Inflammation

    approved small molecule completed

    1 trial

  34. Cosyntropin

    United Therapeutics Europe Ltd

    Postdural Puncture Headache

    approved small molecule completed

    1 trial

  35. CrossBoss Catheter

    United Therapeutics Europe Ltd

    Arteriosclerosis

    approved other completed

    1 trial

  36. Depo-Medroxyprogesterone Acetate

    United Therapeutics Europe Ltd

    HIV

    approved small molecule completed

    1 trial

  37. Dexmedetomidine

    United Therapeutics Europe Ltd

    Breast Cancer

    approved small molecule active

    1 trial

  38. Drawtex dressing

    United Therapeutics Europe Ltd

    Pilonidal Disease

    approved other active

    1 trial

  39. ETHINYL ESTRADIOL AND LEVOGESTREL

    United Therapeutics Europe Ltd

    HIV/AIDS

    approved small molecule completed

    1 trial

  40. Enoxaparin 40 mg q12h

    United Therapeutics Europe Ltd

    Traumatic Injury

    approved small molecule completed

    1 trial

  41. Epoetin Alfa

    United Therapeutics Europe Ltd

    Exercise-Induced Anemia

    approved small molecule completed

    1 trial

  42. Experimental continuous peripheral nerve blocks

    United Therapeutics Europe Ltd

    Lower Extremity Surgical Amputation

    approved small molecule active

    1 trial

  43. FTC-TDF PrEP

    United Therapeutics Europe Ltd

    HIV Infection

    approved small molecule completed

    1 trial

  44. Fenfluramine

    United Therapeutics Europe Ltd

    Cognitive Function

    approved small molecule completed

    1 trial

  45. Fenofibrate 145 mg

    United Therapeutics Europe Ltd

    Diabetic Retinopathy

    approved small molecule completed

    1 trial

  46. Ferric carboxymaltose

    United Therapeutics Europe Ltd

    Anemia

    approved small molecule completed

    1 trial

  47. Gabapentin

    United Therapeutics Europe Ltd

    Peripheral Nerve Disorder Associated With Repair of Hernia

    approved small molecule active

    1 trial

  48. Haloperidol

    United Therapeutics Europe Ltd

    Migraine Headaches

    approved small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does United Therapeutics Europe have?

121 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.